(Q44152479)

30 November 2017

title

The ultrastructure of tomatine adjuvant (English)

1 reference

30 November 2017

Ya-Wun Yang

1

1 reference

30 November 2017

Nadeem A Sheikh

series ordinal

2

1 reference

30 November 2017

W J W Morrow

series ordinal

3

1 reference

30 November 2017

publication date

1 December 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

23

1 reference

30 November 2017

issue

23

1 reference

30 November 2017

page(s)

4677-4686

1 reference

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Adjuvanticity and ISCOM formation by structurally diverse saponins

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Vesicle-micelle transition of phosphatidylcholine and octyl glucoside elucidated by cryo-transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Use of detergents in two-dimensional crystallization of membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

Agarose as crystallization media for proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2802%2900218-1

7 January 2021

10.1016/S0142-9612(02)00218-1

Identifiers

DOI

1 reference

30 November 2017

1 reference